Review articlePublished 28 Aug 2023
Antiviral Drug Resistance in the Age of Emerging Viral Infections
Department of Renal Pathology, Beaumont Hospital, Dublin 9, Ireland
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The emergence of new viral infections, such as COVID-19, Ebola, and Zika, has underscored the importance of effective antiviral treatments. However, the development of antiviral drug resistance presents a formidable challenge to managing these emerging infections. This article examines the intricate interplay between antiviral drug resistance and emerging viral infections. It delves into the factors contributing to resistance development, the susceptibility of emerging infections to resistance, and strategies to mitigate this phenomenon. By exploring the multifaceted nature of antiviral drug resistance in the context of emerging viral threats, this article highlights the urgent need for comprehensive approaches to ensure the continued efficacy of antiviral therapies.
Keywords
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Cellular and Molecular Pharmacology
- SubjectPharmaceutical Sciences
- SubjectGenetics & Molecular Biology
- BylineArticles whose byline prints “Harper Saeed”